Renal Osteodystrophy Clinical Trial
Official title:
A Multicenter, Randomized, Placebo-controlled, Double-blind, 12-month Study to Assess the Effects of an Oral Calcimimetic Agent (AMG 073) on Renal Osteodystrophy in Hemodialysis Patients With Secondary Hyperparathyroidism
4 doses of AMG 073 or placebo over 52 weeks after a 30-day screening period. Throughout the study, labs will be drawn to measure analytes such as iPTH and corrected calcium. In addition, a bone biopsy will be performed at screening and at the end of study.
n/a
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator), Primary Purpose: Treatment
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT03960437 -
The Effect of Etelcalcetide on CKD-MBD
|
Phase 2 | |
| Recruiting |
NCT03716128 -
Diagnosis of Renal Osteodystrophy in Patients With Reduced Renal Function
|
||
| Recruiting |
NCT02147782 -
Clinical Observation on Bone Metabolism Induced by Chronic Renal Insufficiency
|
||
| Completed |
NCT00108394 -
Osteopenia and Renal Osteodystrophy: Evaluation and Management
|
Phase 4 | |
| Completed |
NCT00560300 -
Regulation of Bone Formation in Renal Osteodystrophy
|
Phase 2 | |
| Active, not recruiting |
NCT00752401 -
Vitamin D3 Substitution in Vitamin D Deficient Kidney Transplant Recipients
|
Phase 3 | |
| Completed |
NCT00364234 -
Low Magnitude Mechanical Stimuli Effects on Bone Structure in ESRD
|
N/A | |
| Completed |
NCT00859612 -
Renal Osteodystrophy: A Fresh Approach
|
N/A | |
| Completed |
NCT00004340 -
Phase II Randomized Study of the Effects of Growth Hormone on Children and Adolescents on Maintenance Dialysis
|
Phase 2 | |
| Completed |
NCT01675089 -
Zoledronic Acid to Prevent Bone Loss After Kidney Transplantation
|
Phase 4 | |
| Not yet recruiting |
NCT01382966 -
Serum Sclerostin Levels, Cardiovascular Parameters and Carpal Tunnel Syndrome in Maintenance Hemodialysis Patients
|
N/A | |
| Completed |
NCT03626246 -
Pathogenesis of Compromised Bone Quality and Mechanics in Chronic Kidney Disease
|
||
| Terminated |
NCT00374712 -
Klotho Gene Polymorphism in Dialyzed Patients With Hyperphosphatemia
|
N/A | |
| Terminated |
NCT03960554 -
The Effects of 12-months of Denosumab on Bone Density in Prevalent Kidney Transplant Recipients
|
Phase 2 | |
| Recruiting |
NCT02556216 -
Systematic Study of Parameters of Chronic Kidney Disease Mineral and Bone Disorder (CKD-MBD)
|
N/A | |
| Recruiting |
NCT05880914 -
Precision Medicine Approaches to Renal Osteodystrophy
|
Early Phase 1 | |
| Withdrawn |
NCT01665651 -
Kidney Yin/Yang Replenishment on Patients With Renal Osteodystrophy
|
Phase 2 |